# C_2017331EN.01000601.xml

| 3.10.2017 | EN | Official Journal of the European Union | C 331/6 |
| --- | --- | --- | --- |

3.10.2017

EN

Official Journal of the European Union

C 331/6

---

Prior notification of a concentration

(Case M.8514 — Evonik/DSM/JV)

Candidate case for simplified procedure

(Text with EEA relevance)

(2017/C 331/09)

| 1. | On 22 September 2017, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).
  This notification concerns the following undertakings:






  — | Evonik (Germany), controlled by RAG Stiftung, |
| --- | --- | --- |

1.

On 22 September 2017, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).

1

This notification concerns the following undertakings:

—

Evonik (Germany), controlled by RAG Stiftung,

| — | DSM (Netherlands), |
| --- | --- |

—

DSM (Netherlands),

| — | JV (Netherlands). |
| --- | --- |

—

JV (Netherlands).

Evonik and DSM acquire within the meaning of Article 3(1)(b) and Article 3(4) of the Merger Regulation joint control of the JV.

The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.

| 2. | The business activities of the undertakings concerned are:
  —   for Evonik: production and marketing of speciality chemicals,
  —   for DSM: chemicals company active in nutrition, performance materials and emerging business,
  —   for JV: manufacturing and sales of a product intended to provide an alternative for other sources of Omega-3 fatty acids for the production of animal nutrition. |
| --- | --- |

2.

The business activities of the undertakings concerned are:

—   for Evonik: production and marketing of speciality chemicals,

for Evonik

—   for DSM: chemicals company active in nutrition, performance materials and emerging business,

for DSM

—   for JV: manufacturing and sales of a product intended to provide an alternative for other sources of Omega-3 fatty acids for the production of animal nutrition.

for JV

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.
  Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

2

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
  M.8514 — Evonik/DSM/JV
  Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:





  Email: |
| --- | --- |
| COMP-MERGER-REGISTRY@ec.europa.eu |
| Fax: |
| +32 22964301 |
| Postal address: |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.8514 — Evonik/DSM/JV

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email:

COMP-MERGER-REGISTRY@ec.europa.eu

Fax:

+32 22964301

Postal address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---